Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma.

Bui VM, Mettling C, Jou J, Sun HS.

Open source

DOI
10.1186/s12920-020-00776-z
Published
2020-10-22
Container
BMC Med Genomics
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12920-020-00776-z,
  title = {Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma.},
  author = {Bui VM and  Mettling C and  Jou J and  Sun HS.},
  year = {2020},
  journal = {BMC Med Genomics},
  doi = {10.1186/s12920-020-00776-z},
  url = {https://doi.org/10.1186/s12920-020-00776-z}
}

RIS

TY  - JOUR
TI  - Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma.
AU  - Bui VM
AU  -  Mettling C
AU  -  Jou J
AU  -  Sun HS.
PY  - 2020
JO  - BMC Med Genomics
DO  - 10.1186/s12920-020-00776-z
UR  - https://doi.org/10.1186/s12920-020-00776-z
ER  - 

APA

VM, B., C, M., J, J., & HS., S. (2020). Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma.. BMC Med Genomics. https://doi.org/10.1186/s12920-020-00776-z

Source records